Literature DB >> 24565628

Implantable venous access device associated complications in patients with hereditary angioedema.

Seungjong M Yoo1, David A Khan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24565628     DOI： 10.1016/j.jaip.2013.04.003

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  4 in total

1.  Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States.

Authors:  Marc A Riedl; Aleena Banerji; Michael E Manning; Earl Burrell; Namita Joshi; Dipen Patel; Thomas Machnig; Ming-Hui Tai; Douglas J Watson
Journal:  Orphanet J Rare Dis       Date:  2018-10-12       Impact factor: 4.123

2.  Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks.

Authors:  Jonathan A Bernstein; Huamin Henry Li; Timothy J Craig; Michael E Manning; John-Philip Lawo; Thomas Machnig; Girishanthy Krishnarajah; Moshe Fridman
Journal:  Allergy Asthma Clin Immunol       Date:  2019-03-07       Impact factor: 3.406

Review 3.  Reviewing clinical considerations and guideline recommendations of C1 inhibitor prophylaxis for hereditary angioedema.

Authors:  John Anderson; Njeri Maina
Journal:  Clin Transl Allergy       Date:  2022-01-18       Impact factor: 5.871

4.  Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy.

Authors:  William Lumry; Teri Templeton; Laurel Omert; Donald Levy
Journal:  J Infus Nurs       Date:  2020 May/Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.